Inventor · disambiguated record
Haoquan Wu
Also filed as: WU HAOQUAN
2 granted patents·7 pending applications·4 citations·filing 2008–2023
47Inventor score
Files withKANGLIN BIOTECH HANGZHOU CO LTD3KANGLIN BIOTECHNOLOGY HANGZHOU CO LTD2UNIV TEXAS TECH SYSTEM2HANGZHOU GENEWAY BIOTECHNOLOGY CO LTD1SHANKAR PREMLATA1
Top patents by PatentIndex Score
9 records- 0175US10968451B2Multiplexed shRNAs and uses thereofUNIV TEXAS TECH SYSTEM·Filed 2015·Granted Apr 6, 2021·3 cites·12 claims
- 0266US2024167058A1Nucleic acid constructs and uses thereofKANGLIN BIOTECH HANGZHOU CO LTD·Filed 2023·Application pending·0 cites
- 0362US8772471B2Targeted delivery of siRNASHANKAR PREMLATA·Filed 2008·Granted Jul 8, 2014·1 cites·6 claims
- 0454US2021269804A1Multiplexed shrnas and uses thereofUNIV TEXAS TECH SYSTEM·Filed 2021·Application pending·0 cites
- 0552US2023365990A1Nucleic acid construct for increasing adeno-associated virus yield, and construction method thereforHANGZHOU GENEWAY BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0648US2024352096A1Gene sequence construct for gene therapy of human immunodeficiency virus infectionKANGLIN BIOTECHNOLOGY HANGZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0748US2024391981A1Gene sequence construct for gene therapy for hiv infectionKANGLIN BIOTECHNOLOGY HANGZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0844US2024293576A1Nucleic acid construct for aids gene therapyKANGLIN BIOTECH HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0935US2020397919A1Gene sequence construct used for treatment of central nervous system diseasesKANGLIN BIOTECH HANGZHOU CO LTD·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →